With biotech stocks rallying, Carter Worth and Mike Khouw discuss their calls on Amgen.
With the comeback in older tech stocks, one trader's call on Oracle comes true.
CNBC Senior Contributor Larry Kudlow and Jason Furman, Peterson Institute, discuss Boeing laying off 200 people at one of its U.S. plants where President Trump held a rally about adding jobs to the U.S.
Marc Faber, publisher of the "Gloom, Boom & Doom Report," discusses his market outlook in this one-on-one interview with Courtney Reagan.
The CNBC iQ100 up more than twenty percent over one year. It's an index tracking one hundred big cap companies that get most of their revenue from their own intellectual property. Today's leaders include Western Digital, Oracle, Nabor Industries, Applied Materials and Teradyne. For more go to CNBC.com/iq100.
CNBC's Jackie DeAngelis reports the latest results from CNBC’s CFO survey.
Before the break, health care big cap winners after the sectors jumps eight percent in a quarter our data partners at Kensho show that its happened three times in twelve years. When sold a month after the big jump Merck picks one point seventy-nine percent, Bristol Myers one point seventy-four percent, Pfizer one point forty-eight percent. For more Kensho go to CNBC.com/pro. The Halftime Report with Scott Wapner and the traders are back in two minutes.
Bill Doyle, executive chairman of Novocure, weighs in on the health-care developments in Washington.
There's one index that has a portfolio manager urging investors to start protecting their portfolios.
Cramer spoke one day after health-care stocks posted sharp gains after the Senate released its health bill.